{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T06:13:09Z","timestamp":1788243189882,"version":"build-2803163510"},"reference-count":14,"publisher":"Pensoft Publishers","issue":"2","license":[{"start":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T00:00:00Z","timestamp":1714435200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["FM"],"abstract":"<jats:p><jats:bold>Introduction<\/jats:bold>: Primary hyperparathyroidism (PHPT) is a common endocrine disease with a variable presentation. There is a recent increase in the number of asymptomatic cases due to the use of multichannel automated analyzers.<\/jats:p>\n          <jats:p><jats:bold>Aim<\/jats:bold>: To analyze the changing trend of PHPT patients from South India.<\/jats:p>\n          <jats:p><jats:bold>Materials and methods<\/jats:bold>: We collected the data on clinical presentation, biochemistry, radiological features, and operative findings of patients with PHPT treated in our hospital over a period of six years and looked at the differences between symptomatic and asymptomatic PHPT.<\/jats:p>\n          <jats:p><jats:bold>Results<\/jats:bold>: Our study included 80 patients. A significant proportion (~41%; n=33) of the patients were asymptomatic. Fifty-seven percent of asymptomatic patients were females. Mean age at presentation of asymptomatic patients was 50.58 (\u00b114.67) compared to 47.28 (\u00b114.78) for the symptomatic group, which was not statistically significant (<jats:italic>p<\/jats:italic>=0.34). The mean levels of serum calcium, phosphorous, 25(OH)D, iPTH, and 24-hour urinary calcium in symptomatic vs. asymptomatic patients were 12.47 (\u00b12.26) mg\/dl vs. 12.27 (\u00b11.82) mg\/dl (<jats:italic>p<\/jats:italic>=0.70), 2.59 (\u00b10.74) mg\/dl vs. 2.38 (\u00b10.77) mg\/dl (<jats:italic>p<\/jats:italic>=0.27), 12 (\u00b11.2) ng\/ml vs. 10.85 (\u00b11) ng\/ml (<jats:italic>p<\/jats:italic>=0.78), 1212.5 pg\/ml vs. 678.5 pg\/ml (<jats:italic>p<\/jats:italic>=0.31), and 292.6 mg\/day vs. 262 mg\/day (<jats:italic>p<\/jats:italic>=0.64), respectively. When Ca and gland weight were compared with variations in the iPTH levels, there was a significant positive correlation with PTH &amp;gt;600 pg\/ml (<jats:italic>p<\/jats:italic>=0.001) with no between-group differences. The adenoma weight increased by 0.5291 mg for every unit increase in iPTH in the entire cohort, with no between-group differences (<jats:italic>p<\/jats:italic>=0.52).<\/jats:p>\n          <jats:p><jats:bold>Conclusion<\/jats:bold>: Asymptomatic hyperparathyroidism is increasingly being identified in clinical practice and constitutes a significant proportion of primary hyperparathyroidism. Though asymptomatic PHPT is expected to be milder, such a difference in presentation was not obvious in our study.<\/jats:p>","DOI":"10.3897\/folmed.66.e117637","type":"journal-article","created":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T10:20:19Z","timestamp":1714472419000},"page":"221-226","source":"Crossref","is-referenced-by-count":2,"title":["Emerging pattern of asymptomatic hyperparathyroidism in South India \u2013 a six-year retrospective study"],"prefix":"10.3897","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2178-3860","authenticated-orcid":true,"given":"Ganesh","family":"Viswanathan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9588-1837","authenticated-orcid":true,"given":"Vivek","family":"Mathew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7789-3973","authenticated-orcid":true,"given":"Mallikarjuna","family":"Jeeragi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3492-8347","authenticated-orcid":true,"given":"Belinda","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4343-1719","authenticated-orcid":true,"given":"Ganapathi","family":"Bantwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0548-2956","authenticated-orcid":true,"given":"Vageesh","family":"Ayyar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1526-7432","authenticated-orcid":true,"given":"John","family":"Michael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2258","published-online":{"date-parts":[[2024,4,30]]},"reference":[{"key":"117637_B1","doi-asserted-by":"crossref","unstructured":"1. Yeh MW, Ituarte PHG, Zhou HC, et al. Incidence and prevalence of primary hyperparathyroidism in a racially mixed population. J Clin Endocrinol Metabol 2013; 98(3):1122\u20139.","DOI":"10.1210\/jc.2012-4022"},{"key":"117637_B2","doi-asserted-by":"crossref","unstructured":"2. Bhansali A, Masoodi SR, Reddy KS, et al. Primary hyperparathyroidism in north India: a description of 52 cases. Annals of Saudi Medicine 2005; 25(1):29\u201335.","DOI":"10.5144\/0256-4947.2005.29"},{"key":"117637_B3","doi-asserted-by":"crossref","unstructured":"3. Kamalanathan S, Mahesh D, Vignesh G, et al. Symptomatic primary hyperparathyroidism in Indians. Indian J Endocr Metab 2011; 15(3):229.","DOI":"10.4103\/2230-8210.83413"},{"key":"117637_B4","unstructured":"4. Shah VN, Bhadada S, Bhansali A, et al. Changes in clinical and biochemical presentations of primary hyperparathyroidism in India over a period of 20 years. Indian J Med Res 2014; 139(5):694\u20139."},{"key":"117637_B5","doi-asserted-by":"crossref","unstructured":"5. Mallikarjuna VJ, Mathew V, Ayyar V, et al. Five-year retrospective study on primary hyperparathyroidism in South India: emerging roles of minimally invasive parathyroidectomy and preoperative localization with methionine positron emission tomography-computed tomography scan. Indian J Endocrinol Metab 2018; 22(3):355\u201361.","DOI":"10.4103\/ijem.IJEM_445_16"},{"key":"117637_B6","doi-asserted-by":"crossref","unstructured":"6. Heath H, Hodgson SF, Kennedy MA. Primary hyperparathyroidism. N Engl J Med 1980; 302(4):189\u201393.","DOI":"10.1056\/NEJM198001243020402"},{"key":"117637_B7","doi-asserted-by":"crossref","unstructured":"7. Silverberg SJ, Lewiecki EM, Mosekilde L, et al. Presentation of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metabol 2009; 94(2):351\u201365.","DOI":"10.1210\/jc.2008-1760"},{"key":"117637_B8","doi-asserted-by":"crossref","unstructured":"8. Jayaraman M, Jha S, Jha A, et al. Primary hyperparathyroidism: A changing scenario in India. Indian J Endocr Metab 2016; 20(1):80.","DOI":"10.4103\/2230-8210.172237"},{"key":"117637_B9","doi-asserted-by":"crossref","unstructured":"9. Mithal A, Kaur P, Singh VP, et al. Asymptomatic primary hyperparathyroidism exists in North India: retrospective data from 2 tertiary care centers. Endocrine Practice 2015; 21(6):581\u20135.","DOI":"10.4158\/EP14447.OR"},{"key":"117637_B10","doi-asserted-by":"crossref","unstructured":"10. Arya AK, Kumari P, Bhadada SK, et al. Progressive rise in the prevalence of asymptomatic primary hyperparathyroidism in India: Data from PHPT registry. J Bone Miner Metab 2021; 39(2):253\u20139.","DOI":"10.1007\/s00774-020-01142-w"},{"key":"117637_B11","doi-asserted-by":"crossref","unstructured":"11. Parfitt MA, Rao DS, Kleerekoper M. Asymptomatic primary hyperparathyroidism discovered by multichannel biochemical screening: Clinical course and considerations bearing on the need for surgical intervention. J Bone Miner Res 2009; 6(S2):S97\u2013S101.","DOI":"10.1002\/jbmr.5650061421"},{"key":"117637_B12"},{"key":"117637_B13","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2017.104"},{"key":"117637_B14","doi-asserted-by":"crossref","unstructured":"14. Richert L, Trombetti A. Age and gender distribution of primary hyperparathyroidism and incidence of surgical treatment in a European country with a particularly high life expectancy. Swiss Med Wkly 2009; 138(27-28):400\u20134.","DOI":"10.4414\/smw.2009.12635"}],"container-title":["Folia Medica"],"original-title":[],"link":[{"URL":"https:\/\/foliamedica.bg\/article\/117637\/download\/pdf\/","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/foliamedica.bg\/article\/117637\/download\/xml\/","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/foliamedica.bg\/article_preview.php?id=117637&skip_redirect=1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T10:20:25Z","timestamp":1714472425000},"score":1,"resource":{"primary":{"URL":"https:\/\/foliamedica.bg\/article\/117637\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,30]]},"references-count":14,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,4,30]]}},"URL":"https:\/\/doi.org\/10.3897\/folmed.66.e117637","relation":{},"ISSN":["1314-2143","0204-8043"],"issn-type":[{"value":"1314-2143","type":"electronic"},{"value":"0204-8043","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4,30]]}}}